Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Travel award fund launched in memory of Dr Andrew Bushell

General

TRIG and NDS have launched the Andrew Bushell Travel Bursary Fund in memory of an outstanding senior researcher and lecturer.

Dr Andrew Bushell, who sadly passed away in December 2016, was an integral part of the Wood Lab and later the Transplantation Research Immunology Group (TRIG) in the Nuffield Department of Surgical Sciences. He made many contributions to the field of transplantation and to the Wood Lab/TRIG over the 33 years that he was in the group and is fondly remembered by his friends and colleagues.

To celebrate Andrew's career and his contributions to the success of the Wood Lab/TRIG, the Andrew Bushell Travel Bursary Fund, in collaboration with his widow Ginny and his colleagues, has been set up to help provide travel bursaries for graduate students and early career researchers to attend meetings.  

Read more (Nuffield Department of Surgical Sciences website)

Similar stories

First trimester placental scan - Artificial Intelligence in Health and Care Award

A first trimester 3D placental ultrasound scan which can predict fetal growth restriction and pre-eclampsia, could become part of a woman's routine care thanks to a new Artificial Intelligence in Health and Care Award.

Impaired antibody response to COVID-19 vaccination in patients with myeloid blood cancers

Oxford researchers have found that antibody responses to the first doses of COVID-19 vaccine in people with chronic myeloid blood cancers are not as strong as those among the general population.

Treating Needle Fears May Reduce COVID-19 Vaccine Hesitancy Rates by 10%

A new large-scale study shows that a quarter of the UK adult population screens positive for a potential injection phobia.

RECOVERY trial Regeneron’s monoclonal antibody combination reduces deaths for hospitalised COVID-19 patients

The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial has demonstrated that the investigational antibody combination developed by Regeneron reduces the risk of death when given to patients hospitalised with severe COVID-19 who have not mounted a natural antibody response of their own.

Major new study could help protect millions of people with type 2 diabetes from cardiovascular disease

A new study led by the Nuffield Department of Population Health at the University of Oxford will research whether a daily tablet could help protect the millions of people worldwide with type 2 diabetes from developing cardiovascular disease.

Professor Susan Jebb appointed as Chair of the Food Standards Agency

Susan Jebb, Professor of Diet and Population Health in Oxford University’s Nuffield Department of Primary Care Health Sciences, has been appointed as the new Chair of the Food Standards Agency.